Red light and your brain: a search of 81 studies
Several meta-analyses say red light on your head helps memory, and there is now a home-device trial. What was measured, and where the evidence is thin.

How it is supposed to work
The claim is that light shone at the head reaches the outer layers of the brain, where cytochrome c oxidase absorbs it. That is the same enzyme the rest of this field is built on. Absorbing the light is said to raise ATP production and local blood flow in the tissue under the lamp.
Two things about that are worth holding on to while reading the results. Skull and scalp absorb most of what is aimed at them, so how much light actually arrives is contested rather than measured. And a change in blood flow under a lamp is not the same thing as remembering more, which is what the trials had to show.
The short answer
Shining light at your head to help your memory sounds like something out of an advertisement. It is also one of the best studied uses of red and infrared light there is, and the results point consistently one way.
That is not the same as "it works". Where the evidence is strong and where it is thin differ sharply, and one important caveat that held a year ago has since been overtaken.
Does red light on your head improve memory?
Three independent, pre-registered meta-analyses land in the same place.
The first found that light therapy significantly improved global cognitive function in people with dementia, at SMD 0.63, with near-infrared LEDs and lasers outperforming ordinary visible light [4]. A second, on age-related decline, found a pooled effect across eleven randomised trials of SMD 0.51 [7]. A systematic review of 35 human studies on light to the head specifically found that 82.9 percent reported improvement, in healthy adults as well as in people with impairment [6].
Then a network meta-analysis set all the non-drug options for dementia side by side: 38 studies, 3,412 participants. Photobiomodulation came first, ahead of exercise therapy, cognitive training and enriched environments [5].
Does it work at home or only in a clinic?
Until recently this article carried an important qualification, and it is worth leaving on the page because it shows how fast this field moves.
The meta-analysis on age-related decline split its results by setting. Treatment in a clinic was significant. Home devices were not [7]. The direction was the same, the certainty was not, and that is exactly the distinction that matters if you are considering buying one.
That has now been overtaken.
That is a real result with a real placebo group, in precisely the setting where the evidence had been missing.
But note who did it. This trial and its smaller forerunner from 2025 [2] come from the same research group, with the same device, in the same population. In that earlier, smaller trial (n=26) the MoCA improvement was significant but the MMSE-2 was not.
Two trials by the same makers are not independent confirmation. That is not an accusation: all evidence starts this way. It does mean the next step is replication by somebody else, and that it has not happened yet.
Is it better than brain stimulation?
2026 brought the first head-to-head comparison with the established forms of non-invasive brain stimulation, and it deserves a careful reading.
That distinction is worth understanding, because it recurs constantly in this kind of analysis. Ranking first is not the same as being demonstrably better. The first is a probability calculation, the second is a test. Read only the ranking and you read more certainty than is there.
How much red light, and how often?
One finding runs against intuition and is useful for anybody buying a device.
Tissue rich in mitochondria, such as brain, muscle, heart and nerve, responds to lower doses of light than tissue with fewer of them, such as skin, tendon or cartilage. And where mitochondria-rich tissue showed no benefit, that was more often because the dose was too high than too low [10].
More power is therefore not automatically better in this field, and for your head it is probably the opposite.
The same meta-analysis that separated clinic from home use also found that protocols using multiple wavelengths were significant while single-wavelength protocols were not [7]. That suggests the combination matters more than any single "best" number.
What we think
Of all the uses of red light we have reviewed, this is the one with the most coherent evidence. Several independent meta-analyses point the same way, the effect sizes are not trivial, and there is now a placebo-controlled trial in the setting where it was previously missing.
What is not there: replication by an independent group, follow-up longer than twelve weeks, and any evidence that it does something worthwhile in healthy people without complaints. The trials are about people with a diagnosis.
If you are considering this for yourself without memory problems, you are buying something whose evidence is about somebody else.
Sources
- 1.Chun H, et al. Home-based transcranial photobiomodulation improves cognitive function in mild cognitive impairment due to Alzheimer's disease: randomised clinical trial (n=80, 808 nm, 12 weeks). Journal of Alzheimer's Disease, 2026. PMID: 42024020↩
- 2.Chun H, et al. The efficacy and safety of transcranial photobiomodulation for mild cognitive impairment due to Alzheimer's disease (n=26, home device, 12 weeks). Photobiomodulation, Photomedicine and Laser Surgery, 2025. PMID: 40939031↩
- 3.Xu W, et al. Comparative efficacy and safety of photobiomodulation, transcranial direct current stimulation and repetitive transcranial magnetic stimulation in Alzheimer's disease: network meta-analysis of 35 RCTs. Lasers in Medical Science, 2026. PMID: 42487022↩
- 4.Systematic review and meta-analysis of phototherapy for cognitive function in patients with dementia. PMID: 35847661↩
- 5.Network meta-analysis of non-pharmacological therapies for dementia, including photobiomodulation (38 studies, 3,412 participants). PMID: 36967820↩
- 6.Systematic review of 35 human studies on transcranial photobiomodulation and cognitive function. PMID: 36371017↩
- 7.Systematic review and meta-analysis of photobiomodulation for age-related cognitive impairment (11 RCTs). PMID: 37843594↩
- 8.Systematic review and meta-analysis of photobiomodulation for cognitive deficits in Alzheimer's disease. PMID: 41761363↩
- 9.Systematic review of the therapeutic efficacy of home-use photobiomodulation devices (11 studies). PMID: 31050938↩
- 10.Review of light parameters and photobiomodulation efficacy across tissues of differing mitochondrial density. PMID: 30550048↩

